Retrospective-prospective blinded evaluation predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort.
Abstract at ASCO 2017
Prospective blinded evaluation predicting efficacy of adjuvant cisplatinum and vinorelbine by a multigene assay after radical surgery in non-small cell lung cancer.
Poster at ESMO 2016 Congress
A 71-gene signature of TRAIL sensitivity in cancer cells..
Junjie Chen, Steen Knudsen, Wiktor Mazin, Jesper Dahlgaard, and Baolin Zhang. Published Published OnlineFirst October 25, 2011; doi: 10.1158/1535-7163.MCT-11-0620
Analytical variables influencing the performance of a miRNA based laboratory assay for prediction of relapse in stage I non-small cell lung cancer (NSCLC)..
Jesper Dahlgaard, Wiktor Mazin, Thomas Jensen, Mette Pøhl, Wiam Bshara6, Anker Hansen, Eric Kanisto, Stephen Jacques Hamilton-Dutoit, Olfred Hansen, Henrik Hager, Henrik J Ditzel, Sai Yendamuri, and Steen Knudsen. Published 19 October 2011
Market access challenges in the EU for high medical value diagnostic tests.
Iain Miller†1,2, Joanna Ashton‐Chess, Herman Spolders, Vincent Fert, Joseph Ferrara, Werner Kroll1,7,Jon Askaa,Patrick Larcier, Patrick F Terry, Anne Bruinvels & Alain Huriez1. Published 10.2217/PME.11.2 © 2011 Future Medicine Ltd
Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection..
Patnaik SK1, Kannisto E, Knudsen S, Yendamuri S. Published 2010 Jan 1;70(1):36-45. doi: 10.1158/0008-5472.CAN-09-3153. Epub 2009 Dec 22.